Literature DB >> 20019332

Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.

Suchitra Chandar1, Li Sze Yeo, Christiana Leimena, Ju-Chiat Tan, Xiao-Hui Xiao, Vesna Nikolova-Krstevski, Yoshinori Yasuoka, Margaret Gardiner-Garden, Jianxin Wu, Scott Kesteven, Lina Karlsdotter, Shweta Natarajan, Arthur Carlton, Stephen Rainer, Michael P Feneley, Diane Fatkin.   

Abstract

RATIONALE: Mutations in the LMNA gene, which encodes the nuclear lamina proteins lamin A and lamin C, are the most common cause of familial dilated cardiomyopathy (DCM). Mechanical stress-induced apoptosis has been proposed as the mechanism underpinning DCM in lamin A/C-deficient hearts, but supporting in vivo evidence has been lacking.
OBJECTIVE: Our aim was to study interventions to modify mechanical stress in heterozygous Lmna knockout (Lmna(+/-)) mice. METHODS AND
RESULTS: Cardiac structure and function were evaluated before and after exercise training, thoracic aortic constriction, and carvedilol treatment. Lmna(+/-) mice develop adult-onset DCM with relatively more severe disease in males. Lmna(+/-) cardiomyocytes show altered nuclear morphology and perinuclear desmin organization, with enhanced responses to hypo-osmotic stress indicative of cytoskeletal instability. Despite these structural defects that provide a template for mechanical stress-induced damage, young Lmna(+/-) mice subjected to 6 weeks of moderate or strenuous exercise training did not show induction of apoptosis or accelerated DCM. In contrast, regular moderate exercise attenuated DCM development in male Lmna(+/-) mice. Sustained pressure overload generated by thoracic aortic constriction depressed ventricular contraction in young wild-type and Lmna(+/-) mice with no sex or genotype differences in the time-course or severity of response. Treatment of male Lmna(+/-) mice from 12 to 40 weeks with the beta-blocker, carvedilol, prevented the dilatation and contractile dysfunction that was observed in placebo-treated mice.
CONCLUSIONS: These data suggest that factors other than mechanical stress-induced apoptosis contribute to DCM and provide the first demonstration that regular moderate exercise and carvedilol can modify disease progression in lamin A/C-deficient hearts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019332     DOI: 10.1161/CIRCRESAHA.109.204388

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

1.  A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females.

Authors:  Wenting Chen; Jianhua Huo; Aiqun Ma; Ling Bai; Ping Liu
Journal:  Mol Cell Biochem       Date:  2013-06-22       Impact factor: 3.396

2.  Role of the nuclear envelope in the pathogenesis of age-related bone loss and osteoporosis.

Authors:  Christopher Vidal; Sandra Bermeo; Diane Fatkin; Gustavo Duque
Journal:  Bonekey Rep       Date:  2012-05-02

Review 3.  Second Hits in Dilated Cardiomyopathy.

Authors:  Peter Marstrand; Kermshlise Picard; Neal K Lakdawala
Journal:  Curr Cardiol Rep       Date:  2020-01-24       Impact factor: 2.931

4.  Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.

Authors:  Wei Wu; Mahendra D Chordia; Barry P Hart; E Sathyajith Kumarasinghe; Min K Ji; Ajay Bhargava; Michael W Lawlor; Ji-Yeon Shin; Fusako Sera; Shunichi Homma; Antoine Muchir; Uday R Khire; Howard J Worman
Journal:  Bioorg Med Chem       Date:  2016-12-09       Impact factor: 3.641

Review 5.  Lamin A/C Cardiomyopathy: Implications for Treatment.

Authors:  Suet Nee Chen; Orfeo Sbaizero; Matthew R G Taylor; Luisa Mestroni
Journal:  Curr Cardiol Rep       Date:  2019-11-26       Impact factor: 2.931

Review 6.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 7.  Genetics and disease of ventricular muscle.

Authors:  Diane Fatkin; Christine E Seidman; Jonathan G Seidman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

8.  Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene.

Authors:  Wei Wu; Antoine Muchir; Jian Shan; Gisèle Bonne; Howard J Worman
Journal:  Circulation       Date:  2010-12-20       Impact factor: 29.690

9.  Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.

Authors:  Fresnida J Ramos; Steven C Chen; Michael G Garelick; Dao-Fu Dai; Chen-Yu Liao; Katherine H Schreiber; Vivian L MacKay; Elroy H An; Randy Strong; Warren C Ladiges; Peter S Rabinovitch; Matt Kaeberlein; Brian K Kennedy
Journal:  Sci Transl Med       Date:  2012-07-25       Impact factor: 17.956

10.  Targeting Mitogen-Activated Protein Kinase Signaling in Mouse Models of Cardiomyopathy Caused by Lamin A/C Gene Mutations.

Authors:  Antoine Muchir; Howard J Worman
Journal:  Methods Enzymol       Date:  2015-10-24       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.